Medial Retinacular Plication Versus Medial Patellofemoral Ligament Reconstruction for Recurrent Patellar Instability
NCT ID: NCT02480959
Last Updated: 2020-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2015-08-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Repair of Medial Patellofemoral Ligament Compared to Conservative Treatment for First Time Patella Dislocation
NCT02185001
A Prospective Randomized Study of Medial Patellofemoral Ligament (MPFL) Reconstruction
NCT00816647
The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction
NCT03076008
Navigated Total Knee Arthroplasty, the Correlation to CT Scans and Clinical Results
NCT02071745
PROMs and Patellar Tracking After MPFL Reconstruction With or Without Tibial Tuberosity Transposition
NCT05547269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medial plication
Patient undergoing surgical treatment for recurrent patellar instability that includes medial retinacular plication
Surgical treatment for recurrent patellar instability
Either medial plication or MPFL reconstructuion surgery
MPFL reconstruction
Patient undergoing surgical treatment for recurrent patellar instability that includes medial patellofemoral ligament reconstruction using a tendon graft
Surgical treatment for recurrent patellar instability
Either medial plication or MPFL reconstructuion surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical treatment for recurrent patellar instability
Either medial plication or MPFL reconstructuion surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Imaging criteria include:
* TT-TG distance (on CT or MRI) is between 10-20 mm
* Insall-Salvati Index is between 0.9 - 1.2
* Trochlea angle is lower than 145 degrees
Exclusion Criteria
Imaging criteria include:
* TT-TG distance (on CT or MRI) is below 10 mm or above 20 mm
* Insall-Salvati Index is below 0.9 or above 1.2
* Trochlea angle is above 145 degrees
* Other concomitant intra-articular patholgies, injuries, and surgeries, besides the patella instability, with were recorded at the lower limbs and did not uneventfuly healed, and as a result cause dysfunction of the lower limbs
* Significant ligamentous injuries of the knees, including cruciate and collateral injuries, as well as meniscal injuries that interfere with function
15 Years
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Hadassah Medical Organization
OTHER
Assaf-Harofeh Medical Center
OTHER_GOV
Soroka University Medical Center
OTHER
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
IFTACH HETSRONI, M.D.
Role: PRINCIPAL_INVESTIGATOR
Meir Medical Center
DROR LINDNER, M.D.
Role: PRINCIPAL_INVESTIGATOR
Assaf-Harofeh Medical Center
IDAN ILSAR, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hadassah Medical Organization
MAZEN FALAH, M.D.
Role: PRINCIPAL_INVESTIGATOR
Rambam Health Care Campus
NASSIM ALKRINAWI, M.D.
Role: PRINCIPAL_INVESTIGATOR
Soroka University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir Medical Center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0041-15-MMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.